977 filings
Page 3 of 49
8-K
vpg0r83nbdsp
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
8-K
3whf gvjnertcvoj7eag
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
12:07pm
8-K
hdjdy5f5mehf2h
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am
8-K
2sbe9wc5
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
fkmb0vgg5ckb
2 Oct 23
Entry into a Material Definitive Agreement
6:03am
EFFECT
h15183nq4pn5s9 0b29a
2 Oct 23
Notice of effectiveness
12:15am
424B3
noq8q
29 Sep 23
Prospectus supplement
4:56pm
CORRESP
utvfcrsi7b6l g916l
26 Sep 23
Correspondence with SEC
12:00am
8-K
4osjssal
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
1mgrz
25 Sep 23
Prospectus supplement for primary offering
6:02am
8-K
b2nu7
20 Sep 23
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide
7:00am
UPLOAD
sfonbn b5mg6
20 Sep 23
Letter from SEC
12:00am
8-K
z6z9cewg cl56d
14 Sep 23
Other Events
9:00am
4
pyq3umbu8aee 3ans0e
1 Sep 23
SEELOS THERAPEUTICS / Michael Joseph Golembiewski ownership change
4:15pm
8-K
4sn z9b0q
29 Jun 23
Other Events
9:00am
8-K
nlo peaih
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
5demw sertx8002nv
19 May 23
Entry into a Material Definitive Agreement
5:00pm